Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dr. Scholl's is a globally recognized consumer healthcare brand specializing in foot care and biomechanical solutions. The company's portfolio includes a wide array of orthotic insoles, specialized footwear, and over-the-counter topical treatments for conditions such as warts, fungal infections, and calluses. Founded in 1906 by Dr. William Mathias Scholl, the brand has transitioned through several major pharmaceutical owners, including Schering-Plough, Merck & Co., and Bayer. In 2019, the Americas business was acquired by Yellow Wood Partners, which established the Scholl's Wellness Company to manage the brand. The company remains a market leader in foot health, combining orthopedic engineering with accessible consumer health products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dr. Scholl's.